Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

No reported Deferred Revenue figures are available to summarize.

Deferred Revenue history

Currency unavailable · from the balance sheet

No Deferred Revenue data reported for this period type.

Deferred Revenue vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Deferred Revenue for ODTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PTGXProtagonist Therapeutics, Inc.Jun 2026$9.66M USD-34.2%+417.3%1.1%
ALMSAlumis Inc. Common StockJun 2026$6.67M USD——1.2%
ACRSAclaris Therapeutics, Inc.Mar 2026$3.97M USD——2.0%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€1.69M EUR——1.0%
SYRESpyre Therapeutics, Inc.Sep 2026$0 USD——0.0%
ORKAOruka Therapeutics, Inc.Sep 2026$0 USD——0.0%
ANABAnaptysBio, Inc.Mar 2026$0 USD-100.0%—0.0%
IMUXImmunic, Inc.Mar 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-67.1%+417.3%0.5%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.